Admission Date:  [**2111-8-24**]              Discharge Date:   [**2111-10-12**]  Date of Birth:  [**2049-8-17**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins  Attending:[**First Name3 (LF) 1973**] Chief Complaint: Found unresponsive in driveway  Major Surgical or Invasive Procedure: - Right craniotomy with evacuation of subdural hematoma/intracerebral hemorrage and right temporal lobectomy.
Imaging: CTA HEAD [**2111-8-24**] A 2.9 x 2.5 cm R temporal lobe hgic contusion.
9 mm leftward shift of midline structures.
Multiple fractures involving anterior wall of Rmaxillary sinus, nasal process of R maxillary bone, left zygomatic arch extending to the left sphenoid [**Doctor First Name 362**] and left squamous temporal and parietal bones.
left lateral orbital wall .
CTA: No vascular injury or occlusion identified in source images.
3 D recons pending.
CT HEAD [**8-25**] POST-OP Expected postoperative changes status post evacuation of right-sided subdural hematoma and right temporal intraparenchymal hemorrhage.
There is continued leftward shift of midline structures of 9 mm,  unchanged.Small residual hematoma in the right temporal lobe.
CT Head [**8-26**]: Status post right craniotomy for subdural hemorrhage evacuation,  decreasing size of post-surgical bed with decreased mass effect, evolving intraparenchymal hemorrhage  CT Head [**8-27**]: Little change since the previous study with stable leftward shift of midline structures of approximately 6 mm.
Stable fluid collection overlying the right frontoparietal lobes.
No evidence of acute infarct or hydrocephalus.
Post-operative changes of subdural hematoma evacuation with blood products and air within the subdural space measuring up to 1.4 mm as on the CT obtained earlier on the same day, [**2111-8-28**].
Small amount of subarachnoid and intraventricular blood as well as right temporal hematoma again identified.
No enhancing brain lesions seen on the post-gadolinium images.
No new site of hemorrhage.
Stable opacification of the ethmoidal air cells and layering fluid within bilateral maxillary sinuses.
CTA chest +/- [**9-3**]: No evidence of pulmonary embolism in the first to fifth order pulmonary arteries, although evaluation distal to this level particularly in the lower lobes is limited by atelectasis.
Patulous esophagus with mild gastric distention and pooled airway secretions.
place the patient at risk of aspiration.
Probable tendency to tracheal collapse.
Severe coronary artery disease.
[**9-4**] PCXR:  Increasing left and new large right pleural effusions with associated lower lobe atelectasis.
Persistent gastric distention.
[**9-4**] PCXR: There has been interval decrease in the right-sided pleural effusion.
There remains some minimal blunting of both CP angles consistent with small pleural effusions.
There are no signs for overt pulmonary edema.
[**9-5**] CT A/P w/o con:  No evidence of retroperitoneal hemorrhage.
No CT findings to explain declining hematocrit.
Small bilateral pleural effusions and dependent bibasilar atelectasis.
[**9-7**] TTE: The left atrium is mildly dilated.
No atrial septal defect is seen by 2D or color Doppler.
There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%).
There is no ventricular septal defect.
The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation.
The mitral valve leaflets are mildly thickened.
There is no mitral valve prolapse.
Mild (1+) mitral regurgitation is seen.
The tricuspid valve leaflets are mildly thickened.
There is borderline pulmonary artery systolic hypertension.
There is no pericardial effusion.
[**9-10**] EEG: This telemetry captured no pushbutton activations.
Recording over the 24-hour period showed no epileptiform features or electrographic seizures.
There were no electrographic seizures.
[**9-11**] EEG:  This extended monitoring on [**2111-9-11**] showed a mildly slow background throughout, with more disorganization and posterior delta slowing on the right side.
There were no epileptiform features or electrographic seizures.
Findings may represent underlying atrophy, but continued followup in 24-48 hours is recommended to document stability as hydrocephalus is not excluded.
There is no evidence of transependymal migration of CSF, however.
Stable right frontal subdural collection consistent with patient's known subdural hematoma.
Interval resolution of right temporal intraparenchymal hematoma with residual right middle cranial fossa subdural collection.
Stable 2.4 mm leftward midline shift.
[**2111-10-8**] CT Head: FINDINGS: There is no evidence of acute hemorrhage, large acute territorial infarction, or large masses.
There is a stable right frontal hypodense extra-axial fluid collection consistent with evolution of right subdural hematoma, measuring 12mm in largest diameter.
There is mass effect on adjacent sulci of the right hemisphere.
There is an area of hypodensity at the right temporal lobe at site of prior hemorrhage, with a stable residual right middle cranial fossa small extra-axial fluid collection, 2:7.
There is a focal hypodensity in the left basal ganglia, in keeping with old lacunar ischemic event.
There is no subfalcine or uncal herniation.
There is opacification in several mastoid cells bilaterally.
There is mucosal thickening in the sphenoid sinus.
Findings may represent underlying atrophy.
Hypodensity in the right temporal lobe at the site of prior hematoma with stable residual small right middle cranial fossa subdural collection.
She was also noted to have 9mm of midline shift to the left and subalfcine herniation as well as multiple facial fractures.
Plastics was consulted to evaluate her facial fractures and recommended a dedicated Maxillofacial CT to better evaluate the extent of the fractures.
On [**8-26**], a CT of the cervical spine was obtained to rule out neck injury.
This did not demonstrate any acute cervical fracture.
She remained intubated, as she had a weak gag.
On [**8-28**], on examination, patient was less interactive following no commands, she was brisk with localization in the RUE and brisk w/d in the RLE, but no movement in the LUE to noxious stimuli and spontaneous movement in the LLE toes, but no w/d.
An MRI was ordered to rule out stroke, and this was negative.
Neurology was consulted on [**8-29**], and they recommended continuous EEG monitoring to rule out seizure.
Overnight she was tachycardic and tachypenic.
It did show bilateral effusions with lower lobe collapse.
EKG showed tachycardia and enzymes were orderd and the first CK was 48.
CT chest revealed bilateral pleural effusions on [**9-3**].
The patient underwent thoracentesis and her respiratory status returned to [**Location 213**].
She also developed a UTI with e. coli resistant to bactrim.
She also became quite anemic with a HCT of 18.
An anemia workup revealed decreased reticulocytes as well as iron deficiency.
She underwent CT Abdomen/Pelvis which revealed no evidence of retroperitoneal hemorrhage.
The patient developed hyponatremia to 126.
Hyponatremia stabilized, normalized.
She was also seen by psychiatry for delirium in the setting of multiple [**Date Range 4982**].
SHe was started on Thorazine for restlessness and agitation, and her delirium improved.
On [**10-25**] her delirium and agitation began to slowly worsen, and a urine was checked.
Acetaminophen 650 mg Suppository Sig: One (1) Suppository Rectal Q6H (every 6 hours) as needed for pain or fever.
White Petrolatum-Mineral Oil 56.8-42.5 % Ointment Sig: One (1) Appl Ophthalmic PRN (as needed) as needed for irritation.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
PO DAILY (Daily) as needed for constipation.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed for wheezing.
Polyethylene Glycol 3350 17 gram/dose Powder Sig: Seventeen (17) g PO DAILY (Daily) as needed for constipation.
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical QID (4 times a day) as needed for rash around anus.
Outpatient Lab Work Please check Dilantin (phenytoin) level every other day   Discharge Disposition: Extended Care  Facility: Neuro-Rehabilitation Center - [**Location (un) 7740**]  Discharge Diagnosis: Primary: - Traumatic right temporal ICH s/p lobectomy - Acute on chronic right subdural hematoma - Basilar skull fracture - Multiple facial fractures - Alcohol intoxication - Catheter associated UTI - Generalized seizure - Blood loss anemia - SIADH  Secondary: - Alcohol abuse - Hypertension - Radial nerve compression   Discharge Condition: Mental Status: Confused - sometimes.
Activity Status: Out of Bed with assistance to chair or wheelchair.
You may wash your hair with a mild shampoo ??????
Do NOT apply any lotions, ointments or other products to your incision.
-An over the counter stool softener for constipation (Colace or Docusate).
You have been prescribed Dilantin (Phenytoin) for anti-seizure medicine, take it as prescribed and follow up with laboratory blood drawing.
If you feel light headed or fatigued after increasing activity, rest, decrease the amount of activity that you do, and begin building your tolerance to activity more slowly.
Avoid any activity that causes you to hold your breath and push, for example weight lifting, lifting or moving heavy objects, or straining at stool.
Although your surgery is over, there is the possibility of some of these complications developing.
These complications include: infection, blood clots, or neurological changes.
Confusion, fainting, blacking out, extreme fatigue, memory loss, or difficulty speaking.
Loss of vision, either partial or total.
Numbness, tingling, or weakness in your extremities or face.
Severe sensitivity to light.
Severe headache or change in headache.
Productive cough with yellow or green sputum.
Swelling, redness, or tenderness in your calf or thigh.
New onset of seizure or change in seizure, or seizure from which you wake up confused.
Due to the complexity of neurosurgical procedures and treatment of neurosurgical problems, effective advice regarding emergency situations cannot be given over the telephone.
Should you have a situation which is not life-threatening, but you feel needs addressing before normal office hours or on the weekend, please present to the local emergency room, where the physician there will evaluate you and contact us if needed.
You were also found to have difficulty breathing so we removed fluid from around your lungs.
You had a urinary tract infection which we treated with antibiotics.
There was concern you had a seizure and you were started on anti-seizure [**Telephone/Fax (1) 4982**].
You had low blood counts and no evidence of internal bleeding.
Later in the hospitalization, there was a concern that you were having a seizure and the neurologists started seizure [**Telephone/Fax (1) 4982**].
You later had EEGs of your brain which showed no evidence of seizures.
You had low blood counts but no evidence of bleeding.
You were also found to have a urinary tract infection.
White Petrolatum-Mineral Oil 56.8-42.5 % Ointment: One (1) Appl Ophthalmic as needed as needed for irritation.
Senna 8.6 mg by mouth 2 times a day as needed for constipation.
Bisacodyl 10 mg by mouth daily as needed for constipation.
Polyethylene Glycol 3350 17 gram/dose 17g by mouth daily as needed for constipation.
Miconazole Nitrate 2 % Powder Appl Topical 4 times a day as needed for rash around anus 8.
13. chlorpromazine 25 mg by mouth every 6 hours as needed for severe agitation.
14. acetaminophen 325 mg 1-2 tabs by mouth every 6 hours as needed for Pain 15. simethicone 80 mg Tablet, Chewable by mouth 3 times a day as needed for bloating 16. chlorpromazine 37.5 mg by mouth once a day at bedtime 17. chlorpromazine 25 mg by mouth 3 times a day 18. thiamine HCl 100 mg by mouth daily 19. folic acid 1 mg by mouth daily 20. multivitamin one (1) tablet by mouth daily 21. cyanocobalamin (vitamin B-12) 250 mcg by mouth daily 22. nitrofurantoin (macrocryst25%) 100 mg by mouth 2 times a day for 7 days: Last day of therapy is [**2111-10-13**] 23. valproic acid (as sodium salt) 250 mg/5 mL Syrup Fifteen (15) ml by mouth every night 24. valproic acid 250 mg/5 mL Syrup Ten (10) ml by mouth every morning .
